Surjo R. Soekadar, MD, studied medicine in Mainz, Heidelberg and Baltimore. After a Research Fellowship at the Human Cortical Physiology and Stroke Neurorehabilitation Section (HCPS) at the National Institute of Neurological Disorders and Stroke (NINDS, NIH, USA), he continued his work at the University Hospital of Tübingen, Germany, where he became head of the Applied Neurotechnology Laboratory. In 2018, he transitioned his group to the Charité - Universitätsmedizin Berlin, where is became Germany’s first Professor of Clinical Neurotechnology. He is currently head of the research division 'Translation and Neurotechnology' and medical head of the Center for Translational Neuromodulation. Dr. Soekadar received various prizes and awards such as the NIH-DFG Research Career Transition Award, the NIH Fellows’ Award for Research Excellence, the International BCI Research Award as well as the BIOMAG and NARSAD Young Investigator Awards. Most recently, he received the ERC PoC and Consolidator Grant to develop a bidirectional quantum-BCI.​​​​​​​